Heather M. Schneider

Michael W. Johnson

Virginia Lynch

Zachary S. Travis

Nathan R. Hoeschen

Deborah E. Fishman

Daniel M. Silver

Alexandra M. Joyce

Carson D. Anderson

Abigail Struthers

Jeremy Cobb

ANDA triggers Bayer lawsuit to block Teva's generic KERENDIA®, asserting a reissue patent on a scalable synthesis process for `separating a racemic compound`.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Bayer Healthcare Pharmaceuticals Inc

Bayer Pharma Aktiengesellschaft

Bayer Aktiengesellschaft

Teva Pharmaceuticals USA Inc

Teva Pharmaceuticals Inc

Last Docket Entry Date

Total Docket Entries

1:25-cv-01247 | Bayer Healthcare Pharma Inc v. Teva Pharma Inc | Ex Parte

United States District of Delaware

Name	Ratings
Bayer Healthcare Pharmaceuticals Inc	L5 A
Bayer Pharma Aktiengesellschaft	L5 A
Bayer Aktiengesellschaft	L5 A

Name	Ratings
McCarter & English LLP	L5 A
Daniel M. Silver	L5 A
Alexandra M. Joyce	L5 A
Arnold & Porter Kaye Scholer LLP	L4 A
Deborah E. Fishman	L2 B
Carson D. Anderson	-- -- --
Abigail Struthers	-- -- --
Jeremy Cobb	-- -- --

Name	Ratings
Teva Pharmaceuticals USA Inc	L5 E
Teva Pharmaceuticals Inc	L5 E

Name	Ratings
Shaw Keller LLPLocal	L4 E
Virginia Lynch	-- -- --
Nathan R. Hoeschen	-- -- --
Gemini Law LLP	-- -- --
Heather M. Schneider	-- -- --
Michael W. Johnson	-- -- --
Zachary S. Travis	-- -- --

1:25-cv-01247

Bayer Healthcare Pharmaceuticals Inc v. Teva Pharmaceuticals Inc